However, Gusovsky noted that per the law’s stipulations, prices won’t start to drop until after 2026. To learn more about ...
Another and important means of prevention of neurologic disease after spinal anesthesia involves the proper selection of patients. Afflictions of the central nervous system and spinal column are ...
Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...
Purpose: The role of levetiracetam in different epileptic, nonepileptic, neurologic, and psychiatric disorders is discussed. Summary: Levetiracetam, an antiepileptic drug (AED), was first approved ...
Tomography, Vol. 8, Issue. 1, p. 423. While conventional magnetic resonance, X-ray-based, ultrasound, and nuclear medicine techniques are widely used to facilitate diagnosis, inform therapeutic ...
Building on this success, today we are applying this exciting and pioneering therapeutic approach to other monogenic neurologic and muscle diseases with a scalable platform based on a recombinant ...
The UAB School of Health Professions’ Department of Physical Therapy and UAB Medicine’s Department of Rehabilitation Services are co-sponsoring the UAB Neurologic Physical Therapy Residency Program. A ...
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...
Based on older data, specialists have long debated whether ME/CFS and fibromyalgia, which share overlapping neurologic ...
TUESDAY, Oct. 15, 2024 (HealthDay News) -- Lithium aspartate is not effective for neurologic post-COVID-19 condition (PCC) symptoms of fatigue and cognitive dysfunction, according to a study published ...
BOSTON, Nov. 07, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that the Company ...
The Prix Galien USA Best Startup category recognizes outstanding innovation by therapeutics-focused life science companies that have not yet ...